Abstract
A significant amount of research has addressed strategic alliances however less attention has been paid to how the underlying allocation of control rights within these agreements impacts the performance of alliances. We demonstrate that the theoretical predictions with respect to the allocation of control rights by Aghion and Tirole (1994) have implications for alliance success. Using unique survey data from German biotechnology alliances with pharmaceutical partners we link the ex ante allocation of control rights to ex post alliance success. We find that although incumbent firms are able to draw from more experience and have a larger set of resources in place, relinquishing rights to the young and small research intensive partner may be one way to improve alliance performance. Finally, we are able to comment on which rights may be more important in leading to alliance success.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
